Quantinno Capital Management »

4d Molecular Therapeutics In shares owned by Quantinno Capital Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Quantinno Capital Management from 13F filings

Historical chart of Quantinno Capital Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Quantinno Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Quantinno Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $347k 46k 7.50
2025-09-30 $308k 35k 8.69

More positions owned by Quantinno Capital Management

NVIDIA Corporation Put Option (NVDA)
Apple Put Option (AAPL)
Microsoft Corporation Put Option (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Reddit Cl A Put Option (RDDT)
JPMorgan Chase & Co. Put Option (JPM)
Eli Lilly & Co. Put Option (LLY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Quantinno Capital Management

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Novo A/S
Vanguard Group
State Street Corporation
Henderson Group
Federated Investors
Point72 Asset Management
Millennium Management
Armistice Capital
Geode Capital Management
Evergreen Quality Fund GP
Deutsche Bank Aktiengesellschaft

View all funds holding 4d Molecular Therapeutics In